Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets ; volume:9 ; number:1 ; day:31 ; month:5 ; year:2024 ; pages:1-44 ; date:12.2024
Signal transduction and targeted therapy ; 9, Heft 1 (31.5.2024), 1-44, 12.2024
- Urheber
-
Chen, Runkai
Zhang, Hongrui
Tang, Botao
Luo, Yukun
Yang, Yufei
Zhong, Xin
Chen, Sifei
Xu, Xinjie
Huang, Shengkang
Liu, Canzhao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-024-01840-1
- URN
-
urn:nbn:de:101:1-2407222112161.747846758959
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Runkai
- Zhang, Hongrui
- Tang, Botao
- Luo, Yukun
- Yang, Yufei
- Zhong, Xin
- Chen, Sifei
- Xu, Xinjie
- Huang, Shengkang
- Liu, Canzhao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Monocytes and macrophages in cardiovascular diseases
RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Macrophage-based therapeutic approaches for cardiovascular diseases
Macrophages in organ fibrosis: from pathogenesis to therapeutic targets
MicroRNAs as therapeutic target in cardiovascular disease
The gasdermin family: emerging therapeutic targets in diseases
PERK: a novel therapeutic target for neurodegenerative diseases?
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Artificial intelligence in cardiovascular diseases: diagnostic and therapeutic perspectives
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Monocytes and macrophages in cardiovascular diseases
RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Macrophage-based therapeutic approaches for cardiovascular diseases
Macrophages in organ fibrosis: from pathogenesis to therapeutic targets
MicroRNAs as therapeutic target in cardiovascular disease
The gasdermin family: emerging therapeutic targets in diseases
PERK: a novel therapeutic target for neurodegenerative diseases?
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Artificial intelligence in cardiovascular diseases: diagnostic and therapeutic perspectives
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Monocytes and macrophages in cardiovascular diseases
RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Macrophage-based therapeutic approaches for cardiovascular diseases
Macrophages in organ fibrosis: from pathogenesis to therapeutic targets
MicroRNAs as therapeutic target in cardiovascular disease
The gasdermin family: emerging therapeutic targets in diseases
PERK: a novel therapeutic target for neurodegenerative diseases?
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Artificial intelligence in cardiovascular diseases: diagnostic and therapeutic perspectives